Article
The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
Diabetologia - 1 Oct 2016
Meier Daniel T, Entrup Leon, Templin Andrew T, Hogan Meghan F, Mellati Mahnaz, Zraika Sakeneh, Hull Rebecca L, Kahn Steven E
Abstract excerpt
AIMS/HYPOTHESIS: The S20G human islet amyloid polypeptide (hIAPP) substitution is associated with an earlier onset of type 2 diabetes in humans. Studies of synthetic S20G hIAPP in cell-free systems and immortalised beta cells have suggested that this may be due to increased hIAPP amyloidogenicity and cytotoxicity. Thus, using primary islets from mice with endogenous S20G hIAPP expression, we sought to determine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
